Trials / Withdrawn
WithdrawnNCT04579081
Post Market Clinical Follow-up (PMCF)Study of the Contour Neurovascular SystemTM
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Cerus Endovascular, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
Cerus Endovascular is sponsoring a prospective, multi-center PMCF to document the safety and performance of the Contour Neurovascular System™ (hereinafter "Contour") in normal medical use.
Detailed description
The primary objective of this study is to document the safety and performance of the "Contour Neurovascular System™. The data from the study will be reported as a Post Market study to the Notified Body as part of the Post Market Surveillance (PMS) and Post Market Clinical Follow-up (PMCF) plan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Contour Neurovascular System | Intrasaccular flow disruptor/divertor |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2022-06-01
- Completion
- 2023-06-01
- First posted
- 2020-10-08
- Last updated
- 2022-03-22
Source: ClinicalTrials.gov record NCT04579081. Inclusion in this directory is not an endorsement.